Mesabi Trust - MSB

MSB Returns vs S&P 500 ⓘ

ticker	1 day return %	1 week return %	1 month return %	3 months return %	6 months return %	1 year return %	3 years return %	5 years return %	10 years return %	maximum return %
MSB	0.8	8.1	1.2	14.1	64.4	37.9	-13.4	27.5	59.1	141
S&P 500	1.0	3.7	2.1	2.3	8.2	25.4	31.0	80.6	196.5	33856.2

Compare MSB with other assets →

Returns Charts ⓘ

Interactive Price Chart

Our interactive price chart includes various drawing tools to help you analyze the product more effectively. Below is a quick guide on how to use these tools: Full Guideline

Real-time Full Quote

Attribute	Value
symbol	MSB
name	Mesabi Trust
price	28.92
changes percentage	0.8017
change	0.23
day low	27.25
day high	29.5299
year high	29.72
year low	15.93
market cap	379430689
price avg 50	26.9624
price avg 200	20.90425
exchange	NYSE
volume	86618
avg volume	28332
open	29.04
previous close	28.69
eps	7
pe	4.13
earnings announcement	2024-12-13T21:00:00.000+0000
shares outstanding	13120010
timestamp	2025-01-17 21:00:02

Financial Statements ⓘ

We derive the score of a company's financial statements by evaluating the weighted average sentiment across key within the statements. The cumulative score, normalized to a sum of 1, serves as a metric for assessing the company's performance during the specified period. A higher score indicates stronger performance. However, it's crucial to note that while this score provides valuable insights, it is just one of many factors to consider when making informed investment decisions. A holistic evaluation, considering various aspects of the company's financial health and market conditions, is essential for a well-rounded investment strategy.

Overall Annual Financial Health: 50.0%

Overall Quarterly Financial Health: 67.7%

Income Statements ⓘ

• Annual Income Statement

Note: The years below are fiscal years in accounting.

	2024	2023	Y/Y change %
0000065172
revenue	22862029	7741974	195.30
gross profit	22604965	7409623	205.08
gross profit ratio	0.99	0.96	3.31
research and development expenses	0	0.69	-100.00
operating expenses	3793425	2432889	55.92
interest income	769398	245655	213.20
interest expense	0	0	NaN
ebitda	18544196	5115712	262.49
ebitdaratio	0.81	-0.01	7917.88
operating income	19068604	5389411	253.82
operating income ratio	0.83	0.7	19.82
net income	18983336	5309085	257.56
net income ratio	0.83	0.69	21.08
eps	1.45	0.4	262.50

Overall Score of Annual Income Statement

None

Detailed Analysis

• Quarterly Income Statement

Note: The years below are fiscal years in accounting.

	2025Q3	2025Q2	Q/Q change %
0000065172
revenue	79001840	6489909	1117.30
gross profit	79001840	6489909	1117.30
gross profit ratio	1	1	0.00
research and development expenses	0	0	NaN
operating expenses	7348366	1092015	572.92
interest income	468445	235190	99.18
interest expense	0	0	NaN
ebitda	7348366	0	NaN
ebitdaratio	0.09	0	NaN
operating income	71653474	5397894	1227.43
operating income ratio	0.91	0.83	9.05
net income	78325525	5397894	1351.04
net income ratio	0.99	0.83	19.20
eps	5.97	0.41	1356.10

Overall Score of Quarterly Income Statement

0.86 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Revenue Growth: revenue increased to 79 million in 2025Q3 from 6 million in 2025Q2 representing a change of 1117.3%. This indicates a sales growth, which is a positive sign for the company.

  Gross Profit: Gross Profit increased to 79 million in 2025Q3 from 6 million in 2025Q2 representing a change of 1117.3%. This indicates a sales profitability growth, which is a positive sign for the company.

  EBITDA: EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) increased to 7 million in 2025Q3 from 0 million in 2025Q2 representing a change of nan%. The increase in EBITDA indicates improved operational efficiency and profitability.

  Operating Income: Operating income increased to 72 million in 2025Q3 from 5 million in 2025Q2 representing a change of 1227.43%. The increase in operating income indicates better operational performance and increased profitability.

  Net Income: Net income increased to 78 million in 2025Q3 from 5 million in 2025Q2 representing a change of 1351.04%. The increase in net income shows improved profitability and indicates that the company is generating more profit for each dollar of revenue.

  Earnings per Share (EPS): EPS increased to 5.97 in 2025Q3 from 5.97 in 2025Q2 representing a change of 1356.1%. This indicates that the company's earnings are increasing and it is becoming more profitable on a per-share basis.

• 📉 Negative Indicators

  Operating Expenses: Operating Expenses increased to 7 million in 2025Q3 from 1 million in 2025Q2 representing a change of 572.92%. The increase in operating expenses can be attributed to various factors such as marketing, administrative costs, and investments in infrastructure. It's important to monitor if these expenses are growing at a sustainable rate compared to revenue.

Balance Sheets ⓘ

• Annual Balance Sheet

Note: The years below are fiscal years in accounting.

	2024	2023	Y/Y change %
0000065172
total assets	26690352	14117298	89.06
total liabilities	5715206	2679081	113.33
total equity	-3005302	-2528283	-18.87
cash and cash equivalents	23980448	13966500	71.70
short term investments	0	0	NaN
long term investments	0	1	-100.00
total current assets	26690349	14117295	89.06
total non current assets	3	3	0.00
total current liabilities	5715206	380960	1400.21
total non current liabilities	5715206	2298121	148.69
common stock	3	3	0.00
retained earnings	20975143	11438214	83.38
total debt	1960358	23562	8220.00

Overall Score of Annual Balance Sheet

0.5 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Total Assets: Total Assets increased to 27 million in 2024 from 14 million in 2023 representing a change of 89.06%. Suggesting a growth in asset holdings.

  Cash And Cash Equivalents: Cash And Cash Equivalents increased to 24 million in 2024 from 14 million in 2023 representing a change of 71.7%. This indicates an increase in available liquid assets.

  Total Current Assets: Total Current Assets increased to 27 million in 2024 from 14 million in 2023 representing a change of 89.06%. This indicates a better liquidity position.

  Retained Earnings: Retained Earnings increased to 21 million in 2024 from 11 million in 2023 representing a change of 83.38%. This indicates an accumulated profits.

• 📉 Negative Indicators

  Total Liabilities: Total Liabilities increased to 6 million in 2024 from 3 million in 2023 representing a change of 113.33%. This indicates an increase in overall liabilities.

  Total Equity: Total Equity decreased to -3 million in 2024 from -3 million in 2023 representing a change of -18.87%. This indicates a decrease in shareholders' equity.

  Total Current Liabilities: Total Current Liabilities increased to 6 million in 2024 from 0 million in 2023 representing a change of 1400.21%. This indicates a higher short-term debt burden.

  Total Debt: Total Debt increased to 2 million in 2024 from 0 million in 2023 representing a change of 8220.0%. This indicates an increase in overall debt burden.

• Quarterly Balance Sheet

Note: The years below are fiscal years in accounting.

	2025Q3	2025Q2	Q/Q change %
0000065172
total assets	100667027	26248730	283.51
total liabilities	5342288	4132712	29.27
total equity	95324739	22116018	331.02
cash and cash equivalents	95910149	21631129	343.39
short term investments	0	0	NaN
long term investments	0	0	NaN
total current assets	95910149	26248727	265.39
total non current assets	3	3	0.00
total current liabilities	5342288	4132711	29.27
total non current liabilities	0	0	NaN
common stock	0	3	-100.00
retained earnings	0	0	NaN
total debt	0	0	NaN

Overall Score of Quarterly Balance Sheet

0.57 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Total Assets: Total Assets increased to 101 million in 2025Q3 from 26 million in 2025Q2 representing a change of 283.51%. Suggesting a growth in asset holdings.

  Total Equity: Total Equity increased to 95 million in 2025Q3 from 22 million in 2025Q2 representing a change of 331.02%. This indicates an increase in shareholders' equity.

  Cash And Cash Equivalents: Cash And Cash Equivalents increased to 96 million in 2025Q3 from 22 million in 2025Q2 representing a change of 343.39%. This indicates an increase in available liquid assets.

  Total Current Assets: Total Current Assets increased to 96 million in 2025Q3 from 26 million in 2025Q2 representing a change of 265.39%. This indicates a better liquidity position.

• 📉 Negative Indicators

  Total Liabilities: Total Liabilities increased to 5 million in 2025Q3 from 4 million in 2025Q2 representing a change of 29.27%. This indicates an increase in overall liabilities.

  Total Current Liabilities: Total Current Liabilities increased to 5 million in 2025Q3 from 4 million in 2025Q2 representing a change of 29.27%. This indicates a higher short-term debt burden.

  Common Stock: Common Stock decreased to 0 in 2025Q3 from 0 in 2025Q2 representing a change of -100.0%. This indicates a decrease in ownership interest.

Cashflow Statements ⓘ

• Annual Cashflow Statement

Note: The years below are fiscal years in accounting.

	2024	2023	Y/Y change %
0000065172
net change in cash	10013948	-33761022	129.66
operating cash flow	14605951	13864616	5.35
free cash flow	14605951	13864616	5.35
capital expenditure	0	0	NaN
depreciation and amortization	0	0	NaN
deferred income tax	0	0	NaN
stock based compensation	0	0	NaN
accounts payables	0	0	NaN
inventory	0	0	NaN
acquisitions net	0	0	NaN
investments in property plant and equipment	0	0	NaN
net cash used for investing activites	0	0	NaN
debt repayment	0	0	NaN
common stock issued	0	0	NaN
common stock repurchased	0	0	NaN
dividends paid	-4592003	-47625638	90.36
net cash used provided by financing activities	-4592003	-47625638	90.36
cash at end of period	23980448	13966500	71.70
accounts receivables	-2388692	6039581	-139.55
cash at beginning of period	13966500	47727522	-70.74

Overall Score of Annual Cashflow Statement

1.0 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Net Change in Cash: Net Change in Cash increased to 10 million in 2024 from -34 million in 2023 representing a change of 129.66%. Indicating an increased ability to generate cash from the company's operations or its cash flow position.

  Operating Cash Flow: Operating Cash Flow increased to 15 million in 2024 from 14 million in 2023 representing a change of 5.35%. This indicates that the company generated more cash from its core business operations.

  Free Cash Flow: Free Cash Flow increased to 15 million in 2024 from 14 million in 2023 representing a change of 5.35%. This indicates an increase in cash generated after accounting for capital expenditures.

  Accounts Receivables: Accounts Receivables decreased to -2 million in 2024 from 6 million in 2023 representing a change of -139.55%. This suggests that the company has been able to collect payments from its customers more efficiently and timely.

  Dividends Paid: Dividends Paid increased to -5 million in 2024 from -48 million in 2023 representing a change of 90.36%. This indicates a stronger financial position, more confidence in future prospects, and a better commitment to returning value to shareholders.

• Quarterly Cashflow Statement

Note: The years below are fiscal years in accounting.

	2025Q3	2025Q2	Q/Q change %
0000065172
operating cash flow	78215023	3805959	1955.07
free cash flow	78215023	3805959	1955.07
capital expenditure	0	0	NaN
depreciation and amortization	0	0	NaN
deferred income tax	0	0	NaN
stock based compensation	0	0	NaN
accounts receivables	1912668	-936111	304.32
accounts payables	0	0	NaN
inventory	0	0	NaN
acquisitions net	0	0	NaN
investments in property plant and equipment	0	0	NaN
net cash used for investing activites	0	0	NaN
debt repayment	0	0	NaN
common stock issued	0	0	NaN
common stock repurchased	0	0	NaN
dividends paid	-8659207	-3804803	-127.59
net cash used provided by financing activities	8659207	-3804803	327.59
net change in cash	74279020	1156	6425420.76
cash at end of period	95910149	21631129	343.39
cash at beginning of period	21631129	21629973	0.01

Overall Score of Quarterly Cashflow Statement

0.6 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Net Change in Cash: Net Change in Cash increased to 74 million in 2025Q3 from 0 million in 2025Q2 representing a change of 6425420.76%. Indicating an increased ability to generate cash from the company's operations or its cash flow position.

  Operating Cash Flow: Operating Cash Flow increased to 78 million in 2025Q3 from 4 million in 2025Q2 representing a change of 1955.07%. This indicates that the company generated more cash from its core business operations.

  Free Cash Flow: Free Cash Flow increased to 78 million in 2025Q3 from 4 million in 2025Q2 representing a change of 1955.07%. This indicates an increase in cash generated after accounting for capital expenditures.

• 📉 Negative Indicators

  Accounts Receivables: Accounts Receivables increased to 2 in 2025Q3 from -1 million in 2025Q2 representing a change of 304.32%. This suggests that the company is less capable of collecting payments from its customers.

  Dividends Paid: Dividends Paid decreased to -9 million in 2025Q3 from -4 million in 2025Q2 representing a change of -127.59%. This indicates a weaker financial position, less confidence in future prospects, and a reluctance to return value to shareholders.

Earnings Transcripts ⓘ

No earnings transcripts available.

Earnings Per Share (EPS) ⓘ

Analyst Stock Recommendations ⓘ

Discover detailed analyst recommendations for stocks, including categories such as Buy, Hold, Sell, Strong Buy, and Strong Sell. These insights are based on thorough analysis of financial and market factors. The consensus is calculated by assigning a numerical score to each recommendation. These scores are then weighted and averaged over a specified period to provide a comprehensive view of the stock's outlook, with the final score determining the overall consensus.

Financial Ratios ⓘ

• Annual Financial Ratios

	2024-01-31	2023-01-31	Y/Y change %
FY
calendar year	2024	2023	NaN
revenue per share	1.74	0.59	195.30
net income per share	1.45	0.4	257.56
operating cash flow per share	1.11	1.06	5.35
free cash flow per share	1.11	1.06	5.35
cash per share	1.83	1.06	71.70
book value per share	1.6	0.87	83.38
tangible book value per share	1.6	0.87	83.38
shareholders equity per share	1.6	0.87	83.38
interest debt per share	0.15	0.0	8220.00
market cap	255971395.1	302153830.3	-15.28
enterprise value	233951305.1	288210892.3	-18.83
pe ratio	13.48	56.91	-76.31
price to sales ratio	11.2	39.03	-71.31
pocfratio	17.53	21.79	-19.58
pfcf ratio	17.53	21.79	-19.58
pb ratio	12.2	26.42	-53.80
ptb ratio	12.2	26.42	-53.80
ev to sales	10.23	37.23	-72.51
enterprise value over ebitda	12.62	56.34	-77.61
ev to operating cash flow	16.02	20.79	-22.95
ev to free cash flow	16.02	20.79	-22.95
earnings yield	0.07	0.02	322.07
free cash flow yield	0.06	0.05	24.35
debt to equity	0.09	0.0	4437.08
debt to assets	0.07	0.0	4300.69
net debt to ebitda	-1.19	-2.73	56.43
current ratio	4.67	37.06	-87.40
interest coverage	0	0	NaN
income quality	0.77	2.61	-70.54
dividend yield	0.02	0.16	-88.62
payout ratio	0.24	8.97	-97.30
sales general and administrative to revenue	0.15	0.27	-42.74
research and ddevelopement to revenue	0	0.0	-100.00
intangibles to total assets	0.0	0.0	-47.11
capex to operating cash flow	0	0	NaN
capex to revenue	0	0	NaN
capex to depreciation	0	0	NaN
stock based compensation to revenue	0	0	NaN
graham number	7.21	2.82	156.06
roic	0.91	0.4	128.26
return on tangible assets	0.71	0.38	89.13
graham net net	1.53	1.4	9.39
working capital	20975143	13736335	52.70
tangible asset value	20975145	11438216	83.38
net current asset value	20975143	11438214	83.38
invested capital	20975146	13736338	52.70
average receivables	1217908	3043352.5	-59.98
average payables	0	0	NaN
average inventory	7046866.5	7046867	-0.00
days sales outstanding	38.51	1.11	3366.95
days payables outstanding	0	0	NaN
days of inventory on hand	0	15478.25	-100.00
receivables turnover	9.48	328.58	-97.12
payables turnover	0	0	NaN
inventory turnover	0	0.02	-100.00
roe	0.91	0.46	94.99
capex per share	0	0	NaN

• Positive

  ROE: Return on Equity (ROE) increased to 0.91 on 2024-01-31 from 0.46 on 2023-01-31, representing a change of 94.99%. Suggesting the company has been generating high returns for its shareholders.

• Negative

  PE Ratio: Price-to-Earnings (P/E) Ratio decreased to 13.48 on 2024-01-31 from 56.91 on 2023-01-31, representing a change of -76.31%. Indicating a decrease in the relative valuation of the company's stock.

  Current Ratio: Current Ratio decreased to 4.67 on 2024-01-31 from 37.06 on 2023-01-31, representing a change of -87.40%. The current ratio has been declining, suggesting a decrease in the company's short-term liquidity. Since it's above 3, indicating poor management of working capital.

• Neutral

  Debt-to-Equity Ratio: Debt-to-Equity Ratio increased to 0.09 on 2024-01-31 from 0.00 on 2023-01-31, representing a change of 4437.08%. The debt-to-equity ratio has been increasing, indicating that the company has been relying more on debt financing. Higher leverage may increase financial risk. However, a ratio of 1 or below is often considered healthy and indicates that the company's total debt is equal to or less than its total equity.

• Quarterly Financial Ratios

	2024-10-31 Q3	2024-07-31 Q2	Q/Q change %
MSB
calendar year	2025	2025	NaN
revenue per share	6.02	0.49	1117.30
net income per share	5.97	0.41	1351.04
operating cash flow per share	5.96	0.29	1955.07
free cash flow per share	5.96	0.29	1955.07
cash per share	7.31	1.65	343.39
book value per share	7.27	1.69	331.02
tangible book value per share	7.27	1.69	331.02
shareholders equity per share	7.27	1.69	331.02
interest debt per share	0	0	NaN
market cap	316454641.2	230649775.8	37.20
enterprise value	220544492.2	209018646.8	5.51
pe ratio	1.01	10.68	-90.54
price to sales ratio	4.01	35.54	-88.73
pocfratio	4.05	60.6	-93.32
pfcf ratio	4.05	60.6	-93.32
pb ratio	3.32	10.43	-68.17
ptb ratio	3.32	10.43	-68.17
ev to sales	2.79	32.21	-91.33
enterprise value over ebitda	30.01	0	NaN
ev to operating cash flow	2.82	54.92	-94.87
ev to free cash flow	2.82	54.92	-94.87
earnings yield	0.25	0.02	957.60
free cash flow yield	0.25	0.02	1397.85
debt to equity	0	0	NaN
debt to assets	0	0	NaN
net debt to ebitda	-13.05	0	NaN
current ratio	17.95	6.35	182.66
interest coverage	0	0	NaN
income quality	1.0	0.71	41.63
dividend yield	0.03	0.02	65.88
payout ratio	0.11	0.7	-84.32
sales general and administrative to revenue	0	0	NaN
research and ddevelopement to revenue	0	0	NaN
intangibles to total assets	0.0	0.0	-73.93
capex to operating cash flow	0	0	NaN
capex to revenue	0	0	NaN
capex to depreciation	0	0	NaN
stock based compensation to revenue	0	0	NaN
graham number	31.24	3.95	690.84
roic	0.79	0.24	224.15
return on tangible assets	0.78	0.21	278.36
graham net net	7.16	1.58	353.10
working capital	90567861	22116016	309.51
tangible asset value	95324738	22116017	331.02
net current asset value	90567861	22116015	309.51
invested capital	90567864	22116019	309.51
average receivables	4438799	3856866.5	15.09
average payables	0	0	NaN
average inventory	0	0	NaN
days sales outstanding	5.19	59.98	-91.35
days payables outstanding	0	0	NaN
days of inventory on hand	0	0	NaN
receivables turnover	17.35	1.5	1056.41
payables turnover	0	0	NaN
inventory turnover	0	0	NaN
roe	0.82	0.24	236.65
capex per share	0	0	NaN

• Positive

  ROE: Return on Equity (ROE) increased to 0.82 on 2024-10-31 Q3 from 0.24 on 2024-07-31 Q2, representing a change of 236.65%. Suggesting the company has been generating high returns for its shareholders.

• Negative

  PE Ratio: Price-to-Earnings (P/E) Ratio decreased to 1.01 on 2024-10-31 Q3 from 10.68 on 2024-07-31 Q2, representing a change of -90.54%. Indicating a decrease in the relative valuation of the company's stock.

  Current Ratio: Current Ratio increased to 17.95 on 2024-10-31 Q3 from 6.35 on 2024-07-31 Q2, representing a change of 182.66%. The current ratio has been increasing, suggesting an increase in the company's short-term liquidity. Since it's above 3, indicating poor management of working capital.

Growth Rates ⓘ

• Annual Growth

• Quarterly Growth

Intrinsic Value (Discounted Cash Flow) ⓘ

Positive Sentiment: Discounted Cash Flow value is 58.09 which is higher than current price 28.92, indicates the company may be undervalued.